A comparative clinical trial to study the effect of Darvyadi Niruhabasti and Panchatikta Panchaprasrutik Basti in the management of Kitibha Kushtha(psoriasis)

Assessment of Darvyadi Niruhabasti & Panchatikta Panchaprasrutik Basti in the management of Kitibha Kushtha w.s.r. to Psoriasis - A comparative clinical trial

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/06/042961

Enrollment

Registered

2022-06-01

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L40- Psoriasis

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients presenting with clinical signs and symptoms of Kitibha Kushtha. 2. Kitibha Kushtha patients between the age group of 18 to 70 years. 3. Patients of either gender irrespective of caste and religion.

Exclusion criteria

Exclusion criteria: 1. Patients having other systemic disorders - known case of Hypertension, Carcinoma, Tuberculosis, Infectious diseases and other life threatening disorders. 2. Patients contraindicated for Shodhana such as Pregnant & lactating women.

Design outcomes

Primary

Measure	Time frame
Helps in reduction of signs and symptoms of psoriasis and recurrence of the disease will be controlled.Timepoint: 8 days of treatment After 15 days of treatment follow up	—

Secondary

Measure	Time frame
There will be increased quality of life in psoriasis patients and complications of the disease will be reduced.Timepoint: 25 days	—

Countries

India

Contacts

Public ContactDr Dinesh Patil

Parul Ayurved Hospital

dr.dineshpatil3@gmail.com9039764509

Outcome results